NO20005981L - Anvendelse av 2-hydroksy-4-trifluorbenzosyrederivater som inhibitorer av aktivering av den nukleære transkripsjonsfaktor NF- <kappa>B - Google Patents
Anvendelse av 2-hydroksy-4-trifluorbenzosyrederivater som inhibitorer av aktivering av den nukleære transkripsjonsfaktor NF- <kappa>BInfo
- Publication number
- NO20005981L NO20005981L NO20005981A NO20005981A NO20005981L NO 20005981 L NO20005981 L NO 20005981L NO 20005981 A NO20005981 A NO 20005981A NO 20005981 A NO20005981 A NO 20005981A NO 20005981 L NO20005981 L NO 20005981L
- Authority
- NO
- Norway
- Prior art keywords
- kappa
- hydroxy
- activation
- acid derivatives
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009801154A ES2136581B1 (es) | 1998-05-27 | 1998-05-27 | Uso de derivados del acido-2-hidroxi-4-trifluorometilbenzoico para la preparacion de medicamentos utiles para inhibir el factor de transcripcion nuclear nf-kb. |
PCT/ES1999/000154 WO1999061030A1 (es) | 1998-05-27 | 1999-05-26 | USO DE DERIVADOS DEL ACIDO 2-HIDROXI-4-TRIFLUOROMETILBENZOICO COMO INHIBIDORES DE LA ACTIVACION DEL FACTOR DE TRANSCRIPCION NUCLEAR NF-λB |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20005981D0 NO20005981D0 (no) | 2000-11-27 |
NO20005981L true NO20005981L (no) | 2000-12-12 |
Family
ID=8304002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20005981A NO20005981L (no) | 1998-05-27 | 2000-11-27 | Anvendelse av 2-hydroksy-4-trifluorbenzosyrederivater som inhibitorer av aktivering av den nukleære transkripsjonsfaktor NF- <kappa>B |
Country Status (14)
Country | Link |
---|---|
US (2) | US6414025B1 (es) |
EP (2) | EP1362592A1 (es) |
JP (1) | JP2002516283A (es) |
KR (2) | KR100713601B1 (es) |
AT (1) | ATE245987T1 (es) |
AU (1) | AU3828699A (es) |
BR (1) | BR9911598A (es) |
CA (1) | CA2332863A1 (es) |
DE (1) | DE69910019T2 (es) |
DK (1) | DK1082962T3 (es) |
ES (2) | ES2136581B1 (es) |
NO (1) | NO20005981L (es) |
PT (1) | PT1082962E (es) |
WO (1) | WO1999061030A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2154242B1 (es) * | 1999-09-03 | 2001-10-16 | Uriach & Cia Sa J | Nuevos sistemas polimericos biocompatibles portadores de triflusal o htb. |
US20040101488A1 (en) * | 2000-03-24 | 2004-05-27 | Balaram Ghosh | Method for the prevention of septic shock lethality using curcumin |
ES2190373B1 (es) * | 2001-12-07 | 2004-10-16 | J. URIACH & CIA, S.A. | Uso del acido 2-hidroxi- o 2-acetiloxi-4-trifluorometilbenzoico como agente para el tratamiento y prevencion del deterioro cognitivo ligero. |
WO2004026406A1 (en) | 2002-09-20 | 2004-04-01 | Alcon, Inc. | Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
JP5780521B2 (ja) | 2008-05-28 | 2015-09-16 | リベラジェン・バイオファーマ・インコーポレイテッドReveraGen BioPharma,Inc. | 疾患を治療するための、NF−κBの非ホルモン性ステロイド調節因子 |
MX2021012876A (es) | 2009-03-18 | 2022-06-23 | Resverlogix Corp | Nuevos agentes anti-inflamatorios. |
EP2556083A4 (en) | 2010-04-05 | 2013-12-04 | Validus Biopharma Inc | NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT |
CN103665012B (zh) * | 2013-12-06 | 2016-06-22 | 辽宁师范大学 | 新型三氟柳无机药物化合物及合成方法 |
US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
US20180016314A1 (en) * | 2016-07-12 | 2018-01-18 | Children's Hospital Medical Center | Treatment of disease via transcription factor modulation |
KR101975603B1 (ko) | 2018-09-14 | 2019-08-28 | 이영문 | 조력 발전장치 |
US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4096252A (en) * | 1976-06-10 | 1978-06-20 | J. Uriach & Cia S.A. | 4-Trifluoromethylbenzoic acid derivatives as thromboembolic agents |
IT1276071B1 (it) * | 1995-10-31 | 1997-10-24 | Nicox Ltd | Compositi ad attivita' anti-infiammatoria |
-
1998
- 1998-05-27 ES ES009801154A patent/ES2136581B1/es not_active Expired - Fee Related
-
1999
- 1999-05-26 DK DK99920872T patent/DK1082962T3/da active
- 1999-05-26 WO PCT/ES1999/000154 patent/WO1999061030A1/es active IP Right Grant
- 1999-05-26 KR KR1020007013316A patent/KR100713601B1/ko not_active IP Right Cessation
- 1999-05-26 AU AU38286/99A patent/AU3828699A/en not_active Abandoned
- 1999-05-26 EP EP03012255A patent/EP1362592A1/en not_active Withdrawn
- 1999-05-26 US US09/701,270 patent/US6414025B1/en not_active Expired - Fee Related
- 1999-05-26 AT AT99920872T patent/ATE245987T1/de not_active IP Right Cessation
- 1999-05-26 CA CA002332863A patent/CA2332863A1/en not_active Abandoned
- 1999-05-26 ES ES99920872T patent/ES2204129T3/es not_active Expired - Lifetime
- 1999-05-26 JP JP2000550490A patent/JP2002516283A/ja active Pending
- 1999-05-26 DE DE69910019T patent/DE69910019T2/de not_active Expired - Fee Related
- 1999-05-26 PT PT99920872T patent/PT1082962E/pt unknown
- 1999-05-26 BR BR9911598-0A patent/BR9911598A/pt not_active Application Discontinuation
- 1999-05-26 KR KR1020067026281A patent/KR100762156B1/ko not_active IP Right Cessation
- 1999-05-26 EP EP99920872A patent/EP1082962B1/en not_active Expired - Lifetime
-
2000
- 2000-11-27 NO NO20005981A patent/NO20005981L/no not_active Application Discontinuation
-
2002
- 2002-04-04 US US10/115,140 patent/US6610745B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2136581B1 (es) | 2000-09-16 |
DK1082962T3 (da) | 2003-11-24 |
NO20005981D0 (no) | 2000-11-27 |
JP2002516283A (ja) | 2002-06-04 |
EP1082962A1 (en) | 2001-03-14 |
KR100762156B1 (ko) | 2007-10-04 |
US6610745B2 (en) | 2003-08-26 |
WO1999061030A1 (es) | 1999-12-02 |
ES2204129T3 (es) | 2004-04-16 |
AU3828699A (en) | 1999-12-13 |
BR9911598A (pt) | 2001-02-13 |
DE69910019T2 (de) | 2004-05-06 |
US6414025B1 (en) | 2002-07-02 |
EP1082962B1 (en) | 2003-07-30 |
PT1082962E (pt) | 2003-11-28 |
US20030032630A1 (en) | 2003-02-13 |
KR100713601B1 (ko) | 2007-05-02 |
ES2136581A1 (es) | 1999-11-16 |
ATE245987T1 (de) | 2003-08-15 |
KR20010052404A (ko) | 2001-06-25 |
CA2332863A1 (en) | 1999-12-02 |
EP1362592A1 (en) | 2003-11-19 |
KR20070006943A (ko) | 2007-01-11 |
DE69910019D1 (de) | 2003-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9806752A (pt) | Ftalazinonas. | |
JP2000503980A5 (es) | ||
NO20005981D0 (no) | Anvendelse av 2-hydroksy-4-trifluorbenzosyrederivater som inhibitorer av aktivering av den nukleære transkripsjonsfaktor NF- <kappa>B | |
PT921785E (pt) | Combinacao de enzimas protease acidas e tampoes acidicos e suas utilizacoes | |
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
NO992400L (no) | Nye substituerte pyrazolderivater | |
NO20003233D0 (no) | 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler | |
NO982172L (no) | Anvendelse av epinastin for behandling av smerter | |
BR0109703A (pt) | Derivados de piperazina | |
MX9707980A (es) | Derivados de 4-aminoquinazolina, composiciones que los contienen, y uso de los mismos. | |
BRPI0010891B1 (pt) | geração de microespuma terapêutica. | |
MX9204625A (es) | Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva. | |
BR0110961A (pt) | Derivados de triazol | |
NO991732L (no) | Nye heterocyklylmetylsubstituerte pyrazolderivater | |
DK0840732T3 (da) | Substituerede benzolactamforbindelser som substans P-antagonister | |
BR9911040A (pt) | 2-fenil-1-[4-(2-aminoetóxi)-benzil]-indol em combinação com estrogêneos | |
ITTO950104A0 (it) | Catetere, particolarmente per il trattamento di aritmie cardiache. | |
PT932613E (pt) | Expressao de bloqueio de factoes de virulencia em s. aureus | |
DK0888327T3 (da) | Benzopyranderivater, som har antagonistisk virkning imod leukotriener | |
BR9707247A (pt) | Diidrobenzofurano e compostos relacionados úteis como agentes antiinflamatórios | |
ATE381533T1 (de) | Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung | |
NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
ES2191099T3 (es) | Derivados de hidantoina como productos intermedios para principios activos farmaceuticos. | |
DE69917005D1 (de) | Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung | |
NO20014081L (no) | Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |